Literature DB >> 29541859

Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival.

Tanja Ignatov1, Holm Eggemann1, Elke Burger2, Olaf Ortmann3, Serban Dan Costa1, Atanas Ignatov4,5.   

Abstract

BACKGROUND: Oophorectomy is generally performed in patients with endometrial cancer despite the rate of ovarian metastasis being relatively low. PATIENTS AND METHODS: A multicenter retrospective registry-based study was performed in 2329 patients with endometrial cancer. The outcome measures were the incidence of ovarian metastasis and the impact on overall survival.
RESULTS: Median follow-up was performed at 84 months. A total of 2158 women were eligible for analysis, of which 131 (6.1%) had ovarian metastasis. Women with ovarian metastasis were more likely to have > 50% myometrial invasion, undifferentiated nonendometrioid tumors, and lymph and vascular space invasion. The presence of < 50% myometrial invasion, endometrioid histology, well-differentiated cancer, and negative lymph and vascular space invasion were associated with a very low rate (0.5%) of ovarian metastasis. Notably, after matching for tumor histology and grade, myometrial invasion, and lymph and vascular space invasion, ovarian metastasis was not associated with a reduced median overall survival.
CONCLUSIONS: Ovarian preservation should be offered to premenopausal women with endometrial cancer in whom myometrial invasion is less than 50%, the histological type is endometrioid and well-differentiated, and lymph and vascular space invasion is not involved.

Entities:  

Keywords:  Endometrial cancer; Metastasis; Ovarian

Mesh:

Year:  2018        PMID: 29541859     DOI: 10.1007/s00432-018-2628-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  Survival advantage of lymphadenectomy in endometrial cancer.

Authors:  Holm Eggemann; Tanja Ignatov; Katharina Kaiser; Elke Burger; Serban Dan Costa; Atanas Ignatov
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-08       Impact factor: 4.553

2.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

3.  Evidence-based medicine: an analysis of prophylactic bilateral oophorectomy at time of hysterectomy for benign conditions.

Authors:  C A Larson
Journal:  Curr Oncol       Date:  2011-01       Impact factor: 3.677

4.  Management of elderly women with endometrial cancer.

Authors:  Holm Eggemann; Tanja Ignatov; Elke Burger; Serban Dan Costa; Atanas Ignatov
Journal:  Gynecol Oncol       Date:  2017-06-27       Impact factor: 5.482

5.  Impact of ovarian preservation in women with endometrial cancer.

Authors:  Hei-Yu Lau; Nae-Fang Twu; Ming-Shyen Yen; Hsiao-Wen Tsai; Peng-Hui Wang; Chi-Mou Chuang; Hua-Hsi Wu; Kuan-Chong Chao; Yi-Jen Chen
Journal:  J Chin Med Assoc       Date:  2014-06-05       Impact factor: 2.743

6.  Prognostic factors for uterine cancer in reproductive-aged women.

Authors:  Nita Karnik Lee; Michael K Cheung; Jacob Y Shin; Amreen Husain; Nelson N Teng; Jonathan S Berek; Daniel S Kapp; Kathryn Osann; John K Chan
Journal:  Obstet Gynecol       Date:  2007-03       Impact factor: 7.661

7.  Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis.

Authors:  Gilbert P Pellerin; Michael A Finan
Journal:  Am J Obstet Gynecol       Date:  2005-11       Impact factor: 8.661

8.  Ovarian metastasis in women with clinical stage I endometrial carcinoma.

Authors:  Ofer Gemer; Marina Bergman; Shmuel Segal
Journal:  Acta Obstet Gynecol Scand       Date:  2004-02       Impact factor: 3.636

Review 9.  Improving outcomes for older women with gynaecological malignancies.

Authors:  Lucy Dumas; Alistair Ring; John Butler; Tania Kalsi; Danielle Harari; Susana Banerjee
Journal:  Cancer Treat Rev       Date:  2016-08-29       Impact factor: 12.111

10.  Ovarian metastasis in endometriod type endometrial cancer.

Authors:  Mitra Gilani Modaress; Fatemeh Cheraghi; Narges Zamani
Journal:  Int J Fertil Steril       Date:  2011-12-22
View more
  3 in total

1.  Developing a validated nomogram for predicting ovarian metastasis in endometrial cancer patients: a retrospective research.

Authors:  Peishu Liu; Xiaolei Zhang; Xiaodie Liu; Yaohai Wu
Journal:  Arch Gynecol Obstet       Date:  2021-09-08       Impact factor: 2.344

2.  Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study.

Authors:  Xiaoting Ling; Zheyu Zheng; Jing Xu; Guocai Xu; Hui Zhou; Zhongqiu Lin; Yangyang Li; Jinxiao Liang; Huaiwu Lu
Journal:  Med Sci Monit       Date:  2020-12-25

3.  Assessing Tumor Size by MRI and Pathology in Type I Endometrial Carcinoma to Predict Lymph Node Metastasis.

Authors:  Maria Ali; Mehwish Mumtaz; Zehra Naqvi; Rabia Farooqui; Sania A Shah
Journal:  Cureus       Date:  2022-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.